List of MeSH codes (D26)

Last updated

The following is a partial list of the "D" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM).

Contents

This list continues the information at List of MeSH codes (D25). Codes following these are found at List of MeSH codes (D27). For other MeSH codes, see List of MeSH codes.

The source for this content is the set of 2006 MeSH Trees from the NLM.

MeSH   D26 – pharmaceutical preparations

MeSH   D26.200 – designer drugs

MeSH   D26.255 – dosage forms

MeSH   D26.310 – drug combinations

MeSH   D26.335 – drugs, chinese herbal

MeSH   D26.355 – drugs, essential

MeSH   D26.360 – drugs, generic

MeSH   D26.371 – drugs, investigational

MeSH   D26.393 – drugs, non-prescription

MeSH   D26.526 – materia medica

MeSH   D26.593 – nostrums

MeSH   D26.650 – pharmaceutic aids

MeSH   D26.660 – placebos

MeSH   D26.667 – plant extracts

MeSH   D26.675 – prodrugs

MeSH   D26.776 – solutions

MeSH   D26.878 – street drugs

MeSH   D26.908 – vaginal creams, foams and jellies

MeSH   D26.939 – veterinary drugs

MeSH   D26.969 – xenobiotics

The list continues at List of MeSH codes (D27).

Related Research Articles

Dosage forms are pharmaceutical drug products in the form in which they are marketed for use, with a specific mixture of active ingredients and inactive components (excipients), in a particular configuration, and apportioned into a particular dose. For example, two products may both be amoxicillin, but one is in 500 mg capsules and another is in 250 mg chewable tablets. The term unit dose can also sometimes encompass non-reusable packaging as well, although the FDA distinguishes that by unit-dose "packaging" or "dispensing". Depending on the context, multi(ple) unit dose can refer to distinct drug products packaged together, or to a single drug product containing multiple drugs and/or doses. The term dosage form can also sometimes refer only to the pharmaceutical formulation of a drug product's constituent drug substance(s) and any blends involved, without considering matters beyond that. Because of the somewhat vague boundaries and unclear overlap of these terms and certain variants and qualifiers within the pharmaceutical industry, caution is often advisable when conversing with someone who may be unfamiliar with another person's use of the term.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.